162 related articles for article (PubMed ID: 36844523)
1. Development of Isopropyl-Tailed Chalcones as a New Class of Selective MAO-B Inhibitors for the Treatment of Parkinson's Disorder.
Kumar S; Oh JM; Abdelgawad MA; Abourehab MAS; Tengli AK; Singh AK; Ahmad I; Patel H; Mathew B; Kim H
ACS Omega; 2023 Feb; 8(7):6908-6917. PubMed ID: 36844523
[TBL] [Abstract][Full Text] [Related]
2. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
3. Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones.
Singh AK; Kim SM; Oh JM; Abdelgawad MA; Ghoneim MM; Rangarajan TM; Kumar S; Sudevan ST; Trisciuzzi D; Nicolotti O; Kim H; Mathew B
Chem Biol Drug Des; 2023 Aug; 102(2):271-284. PubMed ID: 37011915
[TBL] [Abstract][Full Text] [Related]
4. Selected 1,3-Benzodioxine-Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors.
Jeong GS; Kaipakasseri S; Lee SR; Marraiki N; Batiha GE; Dev S; Palakkathondi A; Kavully FS; Gambacorta N; Nicolotti O; Mathew B; Kim H
ChemMedChem; 2020 Dec; 15(23):2257-2263. PubMed ID: 32924264
[TBL] [Abstract][Full Text] [Related]
5. Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease.
Manoharan A; Oh JM; Benny F; Kumar S; Abdelgawad MA; Ghoneim MM; Shaker ME; El-Sherbiny M; Almohaimeed HM; Gahtori P; Kim H; Mathew B
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630420
[TBL] [Abstract][Full Text] [Related]
6. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
[TBL] [Abstract][Full Text] [Related]
7. Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole.
Mathew B; Baek SC; Thomas Parambi DG; Lee JP; Mathew GE; Jayanthi S; Vinod D; Rapheal C; Devikrishna V; Kondarath SS; Uddin MS; Kim H
Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800309. PubMed ID: 30663112
[TBL] [Abstract][Full Text] [Related]
8. Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurogenerative disease treatment.
Benny F; Oh JM; Kumar S; Abdelgawad MA; Ghoneim MM; Abdel-Bakky MS; Kukerti N; Jose J; Kim H; Mathew B
RSC Adv; 2023 Nov; 13(50):35240-35250. PubMed ID: 38053684
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors.
Parambi DGT; Oh JM; Baek SC; Lee JP; Tondo AR; Nicolotti O; Kim H; Mathew B
Bioorg Chem; 2019 Dec; 93():103335. PubMed ID: 31606547
[TBL] [Abstract][Full Text] [Related]
10. Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease.
Mathew GE; Oh JM; Mohan K; Tengli A; Mathew B; Kim H
J Biomol Struct Dyn; 2021 Aug; 39(13):4786-4794. PubMed ID: 32588753
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase inhibitory activities of heterocyclic chalcones.
Minders C; Petzer JP; Petzer A; Lourens AC
Bioorg Med Chem Lett; 2015 Nov; 25(22):5270-6. PubMed ID: 26432037
[TBL] [Abstract][Full Text] [Related]
12. Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders.
Vishal PK; Oh JM; Khames A; Abdelgawad MA; Nair AS; Nath LR; Gambacorta N; Ciriaco F; Nicolotti O; Kim H; Mathew B
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34201128
[TBL] [Abstract][Full Text] [Related]
13. Identification of New
El-Damasy AK; Park JE; Kim HJ; Lee J; Bang EK; Kim H; Keum G
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678580
[TBL] [Abstract][Full Text] [Related]
14. Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors.
Alagöz MA; Oh JM; Zenni YN; Özdemir Z; Abdelgawad MA; Naguib IA; Ghoneim MM; Gambacorta N; Nicolotti O; Kim H; Mathew B
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744926
[TBL] [Abstract][Full Text] [Related]
15. Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors.
Oh JM; Rangarajan TM; Chaudhary R; Singh RP; Singh M; Singh RP; Tondo AR; Gambacorta N; Nicolotti O; Mathew B; Kim H
Molecules; 2020 May; 25(10):. PubMed ID: 32443652
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
[TBL] [Abstract][Full Text] [Related]
17. Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach.
Nair AS; Oh JM; Koyiparambath VP; Kumar S; Sudevan ST; Soremekun O; Soliman ME; Khames A; Abdelgawad MA; Pappachen LK; Mathew B; Kim H
Molecules; 2021 May; 26(11):. PubMed ID: 34071665
[TBL] [Abstract][Full Text] [Related]
18. Trimethoxy Crown Chalcones as Multifunctional Class of Monoamine Oxidase Enzyme Inhibitors.
Maliyakkal N; Baysal I; Tengli A; Ucar G; Almoyad MAA; Parambi DGT; Gambacorta N; Nicolotti O; Beeran AA; Mathew B
Comb Chem High Throughput Screen; 2022; 25(8):1314-1326. PubMed ID: 34082669
[TBL] [Abstract][Full Text] [Related]
19. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
[TBL] [Abstract][Full Text] [Related]
20. Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors.
Rehuman NA; Oh JM; Abdelgawad MA; Beshr EAM; Abourehab MAS; Gambacorta N; Nicolotti O; Jat RK; Kim H; Mathew B
Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
